Answers are grounded in this paper and cite their sources.
We have characterized an efficient, 1-step radiolabeling method that produces stable, therapeutically active conjugates of antibodies with (225)Ac at high specific activity. We propose that this technology greatly expands the possible clinical applications of (225)Ac monoclonal antibodies.
No takes yet. Share an insight, caveat, or question.
Maguire et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: